Tuesday, April 20, 2021
Miro Raeber - University Hospital Zurich
Interleukin-2 signals converge in a lymphoid-dendritic cell pathway that promotes anticancer immunity
Interleukin-2 signals converge in a lymphoid-dendritic cell pathway that promotes anticancer immunity